Quarterly report pursuant to Section 13 or 15(d)

Derivative Financial Instruments

v3.21.2
Derivative Financial Instruments
9 Months Ended
Sep. 30, 2020
Investments, All Other Investments [Abstract]  
Derivative Financial Instruments

7. DERIVATIVE FINANCIAL INSTRUMENTS

 

On May 18, 2018, as an inducement to enter into an Amended and Restated Loan Agreement, the Company issued, among other instruments, warrants to acquire 320,000 shares of common stock with an exercise price of $0.10 per share in Canadian dollars (see Note 5). The warrants are valued using the Black Scholes Option Pricing Model and the derivative is fair valued at the end of each reporting period. The Company valued the derivative liability at initial recognition as $30,013.

 

On January 2, 2020, as an inducement to enter into a Loan Agreement, the Company issued warrants to purchase 5,000,000 shares of common stock with an exercise price of $0.10 per share in Canadian dollars (see Note 5) and expire in 36 months. The warrants are valued using the Black Scholes Option Pricing Model and the derivative is fair valued at the end of each reporting period. The Company valued the derivative liability at initial recognition as $144,259.

 

A summary of the activity of the Company’s derivative liabilities is shown below:

 

Balance, January 1, 2019   $ 37,013  
Additions      
Fair value adjustments     (12,504 )
As at December 31, 2019     24,509  
Additions     144,259  
Fair value adjustment     29,369  
As at September 30, 2020   $ 198,137  

 

Derivative liability classified warrants were valued using the Black Scholes Option Pricing Model with the range of assumptions outlined below. Expected life was determined based on historical exercise data of the Company.

 

    September 30, 2020     December 31, 2019  
Risk-free interest rate     2.27 %     1.58% - 2.27 %
Expected life     2.1 years       1.4 – 2.1 years  
Expected dividend rate     0 %     0 %
Expected volatility     208 %     208% - 240 %